Roche Holding AG (RHHVF) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Basel, スイス. 現CEOは Thomas Schinecker.
RHHVF を有する IPO日 2009-02-13, 103,249 名の正社員, に上場 Other OTC, 時価総額 $321.02B.
Roche Holding AG is a Swiss pharmaceutical and diagnostics company founded in 1896 and headquartered in Basel. The company develops and markets pharmaceutical products across multiple therapeutic areas including oncology, neuroscience, infectious diseases, immunology, and respiratory conditions, serving patients globally. Through its diagnostics division, Roche provides in vitro diagnostic tests, instruments, and reagents for detecting diseases such as cancer, cardiovascular conditions, diabetes, and infectious diseases including COVID-19. The company also pursues innovative research collaborations, including partnerships focused on synthetic biology treatments for conditions like inflammatory bowel disease. As an integrated healthcare company, Roche combines its pharmaceutical innovation with diagnostic capabilities to address major healthcare challenges worldwide.
